20.4% CagriSema Trial REDEFINE 2 (NEJM 2025) Duration 68 weeks Population T2D + BMI 27 (n=1,206) Mean Weight Loss 13.7% CagriSema vs 3.4% placebo
Important caution: Given the dual role of glutathione in cancer biology, glutathione or NAC supplementation should NOT be taken during active cancer treatment without oncologist approval, as it could theoretically protect tumor cells from therapy [2][5]
[7] Levocarnitine exerts its therapeutic effect by serving as a carrier molecule that transports activated long-chain fatty acids across the inner mitochondrial membrane
DOI: 10.7759/cureus.94838 #ClinicalResearch #RealWorldEvidence #LatePhaseStudies #PostMarketingStudy #MulticenterStudy #Osteoarthritis #Polmacoxib #PatientCare #HealthcareInnovation #PMOS To view or add a comment, sign in Percutaneous Cryoneurolysis for Above-Knee Phantom Limb Pain: Pilot Study Findings A new pilot study in RAPM investigated whether treating four major nerves in the thigh with ultrasound-guided percutaneous cryoneurolysis could reduce phantom limb pain in patients with above-knee amputations (AKA)
Many men report visible improvements in body composition within 4 to 8 weeks, though individual results depend on training consistency, nutrition, and sleep quality